Celgene
Sign in to saveAlso known as Celgene Corporation
Celgene Corporation is an American pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since its acquisition in 2019.
Key facts
- Company.name
- Celgene Corporation
- Company.logo
- 150px
- Company.type
- Subsidiary
- Company.industry
- Biotechnology
- Company.foundation
- <!--
- Company.defunct
- Celgene is still listed as a significant subsidiary of BMS in its 2025 annual report -->
- Company.parent
- Bristol Myers Squibb
- Company.location
- Summit, New Jersey, U.S.
- Company.key_people
- Robert J. Hugin (executive chairman)Mark Alles (CEO)
- Company.founder
- Sol J. Barer
- Company.products
- RevlimidAbraxanePomalyst/ImnovidThalomidIdhifa
- Company.revenue
- $15.281 billion (2018)
- Company.net_income
- $4.046 billion (2018)
- Company.assets
- $35.480 billion (2018)
- Company.equity
- $6.161 billion (2018)
- Company.num_employees
- 8,852 (2018)
via Wikipedia infobox
Research organization · ROR
- Type
- Company, Funder
- Location
- Summit, United States
- Status
- Inactive
GRID grid.418722.a · ISNI 0000 0004 0461 1802
Official website
Bristol Myers Squibb - Global Biopharmaceutical Company
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
celgene.com →Link to the official site · 9,642 chars · not written by Vinony
Described at
Celgene - Wikirate, an Open ESG Data Platform
wikirate.org →Link to a page describing this subject · 2,793 chars · not written by Vinony
Wikidata facts
- Official website
- www.celgene.com
Show 2 more facts
- inception
- 1986-01-01
- described at URL
- wikirate.org/Celgene
Sources (6)
via Wikidata · CC0
~14 min read
Article
14 sectionsContents
- History
- Company origin and acquisition history
- Management history
- Finances
- Products
- Product-related history
- Pipeline
- Litigation
- Antitrust allegations
- Fraud allegations
- Price increases
- See also
- References
- External links
Celgene Corporation is an American pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since its acquisition in 2019.
==History== Celgene was originally a unit of Celanese. In 1986, Celanese completed the corporate spin-off of Celgene following the merger of Celanese with American Hoechst.